
Johnson & Johnson’s MedTech announce orthopaedics receives 501K clearance from FDA for spinal robotics and navigation platform
Natalia Elliot | August 5, 2024 | News story | Research and Development | 501k clearance, Johnson & Johnson MedTech, Orthopaedics, orthopaedics, robotics, spinal, surgery
Today, the Orthopaedics branch of Johnson & Johnson MedTech, DePuy Synthes, has announced that their surgical robotics system VELYS active has received 501k clearance from the US Food and Drug Administration (FDA).
“We are shaping the next frontier of orthopaedic innovation with a relentless focus on digital advancements and excellence in the field of surgical robotics and navigation. Our dedication extends to enhancing patient care through significant strides in spine surgery,” said Aldo Denti, company group chair, DePuy Synthes.
In collaboration with eCential Robotics, the dual-use robotics and standalone navigation platform is designed for use in planning and instrumenting spinal fusion procedures in the thoracolumbar, cervical and sacroiliac spine.
Russel Powers, worldwide president, Spine, DePuy Synthes added: “Today’s landscape of enabling technologies features first-generation robotics systems that may face challenges in adapting to individual surgeon needs”.
Natalia Elliot
5/8/24
Related Content

J&J MedTech to work with NVIDIA for surgical AI
Johnson & Johnson (J&J) MedTech has announced that it is working in collaboration with NVIDIA …

J&J’s to submit surgical robot to FDA in 2024
Johnson & Johnson MedTech have announced plans to submit the Ottava robotic surgical system to …

Rani Therapeutics’ oral ‘robotic pill’ delivers injection trans-enterically
US Rani Therapeutics, a clinical-stage biotherapeutics company, has reported new results from its phase 1 …






